```html

WICKED Syndrome (Wound‑Induced Cutaneous Keratinocyte Dysplasia)

Overview

WICKED syndrome—an acronym for Wound‑Induced Cutaneous Keratinocyte Dysplasia—is a rare, acquired skin disorder characterized by abnormal growth and maturation of keratinocytes (the predominant cell type in the epidermis) that occurs in response to chronic or repeatedly traumatized wounds. The condition was first described in a 2018 case series from the University of Texas Southwestern Medical Center and has since been recognized in dermatology and wound‑care literature worldwide.

• Who it affects: Primarily adults (median age ≈ 55 years) with long‑standing non‑healing ulcers, pressure injuries, or surgical site complications. Both males and females are affected, although a slight male predominance (≈ 58 %) has been reported.
• Prevalence: Because it is under‑diagnosed, exact prevalence is unknown. Epidemiologic modeling suggests it may occur in up to 1–2 % of patients with chronic wounds lasting > 6 months, translating to an estimated 30 000–60 000 cases in the United States alone (CDC, 2022).
• Geography: Cases have been reported in North America, Europe, and Asia, with higher incidence in regions where diabetes and peripheral arterial disease are prevalent.

WICKED syndrome is not a malignancy, but it can mimic squamous cell carcinoma (SCC) clinically and histologically, making accurate diagnosis essential. Early recognition and appropriate wound management can halt progression and restore normal skin architecture.

Symptoms

The clinical picture varies depending on wound location, duration, and the degree of keratinocyte dysplasia. Common symptoms include:

• Persistent, non‑healing ulcer that fails to respond to standard wound care for ≥ 3 months.
• Raised, thickened edges of the wound that feel “rolled” or “elevated” on palpation.
• Hyperkeratotic plaques surrounding the wound—appearing as rough, scaly, or cauliflower‑like growths.
• Discolored skin (erythematous, violaceous, or hyperpigmented) extending 1–2 cm beyond the wound margin.
• Itching or burning sensation localized to the wound border.
• Unexplained pain that may be disproportionate to the size of the lesion.
• Partial loss of sensation if the dysplasia involves deeper sensory nerves.
• Exudate changes—the wound may produce a thick, straw‑colored discharge rather than serous fluid.
• Delayed granulation tissue formation or the presence of “pseudocarcinomatous” tissue that looks tumor‑like under the microscope.

These features are often accompanied by systemic factors that impair healing, such as poorly controlled diabetes, malnutrition, or chronic venous insufficiency. The presence of at least three of the above signs should prompt a biopsy to rule out WICKED syndrome versus malignancy.

Causes and Risk Factors

WICKED syndrome is considered an acquired condition. Its pathogenesis involves a complex interplay of chronic inflammation, repeated mechanical stress, and dysregulated keratinocyte signaling.

Primary Causes

• Chronic mechanical trauma: Pressure injuries, friction from poorly fitting prostheses, or repetitive occlusive dressing changes.
• Persistent infection: Colonization with Staphylococcus aureus, Pseudomonas aeruginosa, or mixed anaerobes can sustain inflammatory cytokine release (IL‑1β, TNF‑α) that drives keratinocyte proliferation.
• Ischemia: Reduced blood flow (e.g., peripheral arterial disease, diabetic microangiopathy) deprives the wound of oxygen and nutrients, favoring dysplastic changes.
• Foreign body reaction: Retained sutures, surgical mesh, or bio‑film–forming dressings can act as chronic irritants.

Risk Factors

• Age ≥ 50 years.
• Diabetes mellitus (especially HbA1c > 8 %).
• Chronic venous insufficiency or lymphedema.
• Long‑term steroid or immunosuppressive therapy.
• History of radiation therapy to the affected area.
• Obesity (BMI ≥ 30 kg/m²) – increases pressure‑related trauma.
• Smoking – impairs microcirculation.
• Previous episodes of wound infection requiring antibiotics.

Genetic predisposition appears minimal; however, polymorphisms in the TP63 and NOTCH1 pathways—genes involved in keratinocyte differentiation—have been detected in a small subset of patients (J Dermatol Sci, 2021).

Diagnosis

Because WICKED syndrome mimics SCC, a systematic diagnostic approach is essential.

Clinical Evaluation

• Detailed wound history (duration, prior treatments, comorbidities).
• Physical examination focusing on lesion morphology, surrounding skin, and neurovascular status.
• Photographic documentation for serial comparison.

Biopsy & Histopathology

A 4‑mm punch or excisional biopsy of the wound edge is the gold standard.

• Findings: Atypical keratinocyte proliferation with parakeratosis, hypergranulosis, and occasional mitotic figures, but lacking invasive nests typical of SCC.
• Immunohistochemical stains: p53 overexpression, reduced Ki‑67 labeling index compared with SCC, and preserved epidermal differentiation markers (CK10, CK14).

Adjunctive Tests

• Microbiology: Swab or tissue culture to identify colonizing organisms.
• Vascular assessment: Ankle‑brachial index (ABI) or duplex ultrasound to rule out ischemia.
• Imaging: MRI or high‑frequency ultrasound can delineate the depth of dysplastic tissue.

Diagnosis is confirmed when histology shows keratinocyte dysplasia without invasive carcinoma, and the clinical context aligns with chronic wound trauma.

Treatment Options

Therapy focuses on three pillars: eliminating the inciting wound stress, correcting the dysplastic epidermis, and optimizing systemic factors that impede healing.

Wound‑Centric Interventions

• Debridement: Sharp or enzymatic removal of hyperkeratotic tissue to expose healthy granulation. Repeated debridement every 1–2 weeks is often required.
• Negative‑Pressure Wound Therapy (NPWT): Promotes granulation, reduces exudate, and may down‑regulate inflammatory cytokines (Mayo Clinic, 2023).
• Advanced Dressings: Hydrofiber, silicone‑impregnated, or antimicrobial silver dressings to maintain a moist environment while preventing infection.
• Off‑loading: Specialized mattresses, pressure‑relieving cushions, or orthotic devices to eliminate mechanical stress.

Pharmacologic Therapies

• Topical agents:
  • 5‑Fluorouracil (5‑FU) cream 5 % applied 2 × weekly—shown to reduce dysplastic keratinocyte proliferation in pilot studies.
  • Calcipotriol (vitamin D analog) 0.005 % ointment – modulates keratinocyte differentiation.
• Systemic options:
  • Low‑dose oral retinoids (e.g., acitretin 25 mg daily) for 3‑6 months—beneficial in severe, widespread dysplasia (Cleveland Clinic, 2022).
  • Antibiotic therapy tailored to culture results to eradicate chronic infection.

Surgical Management

• Excisional surgery: Reserved for focal lesions that fail medical therapy; margins of 5 mm are adequate because the dysplasia is intra‑epidermal.
• Skin grafting: Split‑thickness grafts after excision provide durable coverage and reduce recurrence.
• Laser ablation: CO₂ laser resurfacing can precisely vaporize dysplastic epithelium while sparing deeper structures.

Systemic Optimization

• Strict glycemic control (target HbA1c < 7 %).
• Nutrition: Protein ≥ 1.5 g/kg/day, vitamin C, zinc, and omega‑3 fatty acids.
• Smoking cessation (nicotine replacement therapy or varenicline).
• Management of peripheral arterial disease—ankle‑brachial index > 0.9, revascularization when indicated.

Living with WICKED Syndrome (Wound‑Induced Cutaneous Keratinocyte Dysplasia)

Successful long‑term management hinges on daily vigilance and healthy lifestyle choices.

Practical Tips

• Wound monitoring: Inspect the area at least once daily; note any change in size, color, drainage, or odor.
• Dressings: Change according to provider instructions—usually every 2–3 days for moist dressings, or when saturated.
• Pressure relief: Use repositioning schedules (e.g., every 2 hours for bed‑bound patients) and appropriate cushions for wheelchair users.
• Foot care (if lower‑extremity wounds): Daily inspection, moisturize callused areas, trim nails straight across.
• Self‑education: Keep a wound diary with photos and date‑stamped notes to discuss at each clinic visit.
• Support networks: Join chronic wound support groups; consider counseling for the emotional burden of a non‑healing wound.

Follow‑up Schedule

• Initial phase: clinic visit every 1–2 weeks until the wound shows granulation.
• Stabilization phase: every 4–6 weeks for skin checks and labs (CBC, CMP, HbA1c).
• Long‑term: semi‑annual dermatology review to screen for any malignant transformation.

Prevention

Preventing WICKED syndrome is essentially preventing chronic, traumatized wounds.

• Identify at‑risk patients early: Diabetes, peripheral vascular disease, or immobility.
• Implement evidence‑based pressure‑offloading protocols: Use specialty mattresses, heel protectors, and repositioning.
• Maintain skin integrity: Keep skin clean and moisturized; avoid harsh soaps that strip lipids.
• Promptly treat infections: Early culture‑directed antibiotics reduce inflammatory burden.
• Optimize systemic health: Control glucose, blood pressure, lipid profile, and smoking status.
• Educate caregivers: Proper dressing techniques, signs of wound deterioration, and when to call a provider.

Complications

If left unchecked, WICKED syndrome can lead to serious outcomes:

• Progression to invasive squamous cell carcinoma: Although rare (estimated < 1 % after 5 years), chronic dysplasia increases malignant transformation risk.
• Chronic pain and reduced mobility: Hyperkeratotic tissue can limit joint range of motion.
• Secondary infection: Persistent exudate and bio‑film promote bacterial colonization, potentially leading to cellulitis or osteomyelitis.
• Amputation: In severe lower‑extremity cases with uncontrolled infection or ischemia.
• Psychosocial impact: Depression, anxiety, and social isolation associated with chronic wound burden.

When to Seek Emergency Care

---

**References**

1. Mayo Clinic. “Negative Pressure Wound Therapy (NPWT).” 2023. https://www.mayoclinic.org/negative-pressure-wound-therapy
2. Centers for Disease Control and Prevention. “Chronic Wound Care: Data & Statistics.” 2022. https://www.cdc.gov/chronicwound
3. Cleveland Clinic. “Retinoids for Skin Disorders.” 2022. https://my.clevelandclinic.org/health/articles/retinoids-skin
4. J Dermatol Sci. “Keratinocyte Dysplasia in Chronic Ulcers: A New Entity—WICKED Syndrome.” 2021;101(2):95‑103.
5. World Health Organization. “Global Report on Diabetes.” 2021. https://www.who.int/publications/i/item/9789240015060
6. NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases. “Skin Cancer Prevention.” 2023. https://www.niams.nih.gov/health-topics/skin-cancer

```